Rinet Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Rinet Company's BMY Position: Q3 2021 in Review
Rinet Company increased its Bristol-Myers Squibb (BMY) stake by 4.2% in Q3 2021, buying an estimated $12.2K and bringing the position to 4,597 shares worth $272K. The position accounts for 0.05% of the portfolio, ranked #72.
Rinet Company first reported a position in BMY in Q1 2021 and has held it in 3 quarters since. The position peaked at $295K in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Rinet Company held 4,597 shares of Bristol-Myers Squibb worth $272K as of Q3 2021.
- Rinet Company bought 186 Bristol-Myers Squibb shares in Q3 2021, an estimated $12.2K.
- Bristol-Myers Squibb made up 0.05% of Rinet Company's portfolio in Q3 2021, its #72 holding.
- Rinet Company first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 3 quarters since.
- Rinet Company's Bristol-Myers Squibb position peaked at $295K in Q2 2021.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Rinet Company's 13F filing for Q3 2021, filed 12 Nov 2021.